Active-ingredient Dossier
Tranexamic Acid
Active-ingredient Dossier for Tranexamic Acid (antifibrinolytic agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: TRANEXAMIC
- Brand: APO-TRANEXAMIC
- Brand: TRANEXAMIC
- Brand: TRANEXAMIC
- Brand: TRANEXAMIC
- Brand: Tranexamic-AFT
- Therapeutic area: Haematology
- Therapeutic area: Uncategorised
What is
Tranexamic Acid Tranexamic Acid is an antifibrinolytic agent.
Australian brands containing Tranexamic Acid
— TRANEXAMIC — APO-TRANEXAMIC — Tranexamic-AFT — ZAMIC — CYKLOTRAN — CYKLOTRANEXAMIC — Juno Pharmaceuticals
Therapeutic areas
Tranexamic Acid is registered in cardiology (9 brands), uncategorised (2 brands), and haematology (1 brand).
Sponsor landscape
Tranexamic Acid is marketed by eight sponsors: MedTAS, Southern Cross Pharma, Medsurge Pharma, LumaCina, Juno Pharmaceuticals, and Arrotex Pharmaceuticals.
PBS and regulatory activity
The latest AusPAR for Tranexamic Acid was published on 10 September 2010. No brands containing this ingredient have PBAC outcomes on record.